Author

Irene Paassen

Observed names: Irene Evelyn Karla Paassen, Paassen, Irene

Institutions: University of Bern, Oncode Institute, Princess Máxima Center

Observed institutions: University of Bern, Oncode Institute, Princess Máxima Center

ORCID: 0009-0000-7737-3292

Observed ORCID: 0009-0000-7737-3292

OpenAlex ID: A5004423259

Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors

2021 · Camilla Calandrini, Sander R. van Hooff, et al. · Cell Reports · 63

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

2023 · Irene Paassen, Justin Williams, et al. · Oncogene · 40

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors

2023 · Ning Qing Liu, Irene Paassen, et al. · Nature Communications · 38

A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al. · Cancer Research · 9

A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories

2025 · Enrique Blanco-Carmona, Irene Paassen, et al. · Neuro-Oncology · 7

In vitro Modeling of Embryonal Tumors

2021 · Lars Custers, Irene Paassen, et al. · Frontiers in Cell and Developmental Biology · 7

Cell surface proteomics of patient-derived malignant rhabdoid tumor organoids identifies ROBO1 as CAR T cell target for pediatric solid tumors

2026 · Juliane L. Buhl, Jannet Koelewijn, et al. · Nature Communications · 3

CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia

2023 · Pauline Schneider, Priscilla Wander, et al. · International Journal of Molecular Sciences · 3

Going beyond genomics in precision oncology

2026 · Irene Paassen, Mark A. Rubin · Nature Medicine · 2

A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

2026 · Thienger, Phillip, Paassen, Irene, et al. · Open Access CRIS of the University of Bern

Supplementary Figure S12 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S5 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S7 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Tables S1-S6 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S8 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S13 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S6 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S4 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S2 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Data from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S10 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S9 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S11 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Supplementary Figure S3 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

2026 · Phillip Thienger, Irene Paassen, et al.

Works count: 31

Citation count: 172

H-index: 6

I10-index: 3